Select Language
Free Registration
My Cart

GDP-Fuc-vc-PAB-MMAE

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Belatacept biosimilar (Alphamab)KN-019Phase 2 ClinicalSuzhou Alphamab Co LtdRejection of renal transplantation; Arthritis, Rheumatoid
Details
ORCA-010ORCA-010Phase 2 ClinicalOrca Therapeutics BvProstatic Neoplasms
Details
Membrane bound ligand T-SIGn virusNG-348Phase 1 ClinicalAkamis Bio LtdNeoplasms
Details
Chimeric antigen receptor T-cell therapy (Hunan Zhaotai Yongren Biotech)Z-CTLsPhase 1 ClinicalHunan Zhaotai Yongren Biotech Co LtdCarcinoma, Non-Small-Cell Lung
Details
Abatacept biosimilar (Dr. Reddy's Laboratories)DRL-ABPhase 1 ClinicalDr.Reddy's Laboratories LtdArthritis, Rheumatoid
Details
SG-1827SG1827; SG-1827Phase 1 ClinicalHangzhou Sumgen Biotechnology Co LtdSolid tumours
Details
Recombinant human CTLA-4-FC fusion protein(Beijing Vdjbio)Phase 1 ClinicalBeijing Vdjbio Co LtdArthritis, Rheumatoid
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
BelataceptLEA29Y; LEA-029; BMS-224818; L104EA29YIgApprovedBristol-Myers Squibb CompanyNulojixUnited StatesRejection of renal transplantationBristol-Myers Squibb Company2011-06-15Rejection of renal transplantation; Diabetes Mellitus, Type 1; Proteinuria; Pancreatic neuroendocrine tumors (pNET); Arthritis, Rheumatoid; Delayed Graft Function; Rejection of organ transplantation; Rejection in heart transplantation; Kidney Failure, Chronic
Details
AbataceptONO-4164SC; BMS-188667SC; ONO-4164; BMS-188667ApprovedBristol-Myers Squibb CompanyOrencia, 恩瑞舒United StatesArthritis, RheumatoidBristol-Myers Squibb Company2005-12-23Anemia, Aplastic; Arthralgia; Uveitis; Cardiovascular Diseases; Healthy Aging; Urticaria; Sjogren-Larsson Syndrome; Arthritis, Psoriatic; Colitis, Ulcerative; Arthritis; Takayasu Arteritis; Glomerulosclerosis, Focal Segmental; Lupus Erythematosus, Systemic; Psoriasis; Allergic asthma; Shwachman-Diamond Syndrome; Mucopolysaccharidosis I; Lymphohistiocytosis, Hemophagocytic; Anemia, Sickle Cell; Thrombasthenia; Kostmann Syndrome; Behcet Syndrome; Vitiligo; Crohn Disease; Muscular Diseases; Granulomatous Disease, Chronic; Lung Diseases, Interstitial; Leukocyte-Adhesion Deficiency Syndrome; Inflammation; Common Variable Immunodeficiency; Myocarditis; Eye Diseases; Scleroderma, Diffuse; Nephrotic Syndrome; Polymyositis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Myositis; Alopecia Areata; Immunoglobulin G4-Related Disease; Dermatomyositis; Giant Cell Arteritis; Diabetes Mellitus, Type 1; Graft vs Host Disease; Hematologic Diseases; Wiskott-Aldrich Syndrome; Myasthenia Gravis; Polychondritis, Relap
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland